| First Published on Clinicaltrials.gov: |
1/9/2009 |
| Status: |
Currently Recruiting |
| ClinicalTrials.gov ID: |
NCT00821132 |
| Sponsor: |
Northwestern University |
| Purpose: |
The investigators long term goals are to improve diagnosis and develop effective treatments that arrest or ameliorate symptoms of ALS, and possibly delay or prevent disease onset in individuals at risk for developing familial ALS (FALS). In order to do this one must understand how disease develops at a molecular level. Identification of genes that increase risk for developing all types of ALS will reveal the pathways of molecular events that are involved in ALS. |
| Phase: |
|
| Treatment Type: |
Collection of Images |
| Trial Type: |
Other |
| Estimated Enrollment: |
15000 |
| Eligibility: |
18 years and older. Both Genders. Acceepts healthy volunteers. |
| Details: |
Collection and analysis of genetic material (whole blood and/or CSF samples), medical and family histories from families with ALS. |
| Collaborator(s): |
|
| Location(s): |
- Chicago, IL, 60611, United States
|
| Primary Investigator: |
Teepu Siddique, MD Northwestern University Feinberg School of Medicine Neuromuscular Disorders Program |
| Contact: |
|
| Trial Protocol as Published on Clinicaltrials.gov: |
|
| ALS Forum: |
|